- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥36.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥83.05
7D
-1.5%
1Y
-12.9%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥34.0b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥56.83
7D
3.0%
1Y
-1.3%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥13.0b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥37.43
7D
1.3%
1Y
5.7%